Cargando…

What matters: non-pharmaceutical interventions for COVID-19 in Europe

OBJECTIVES: The purpose of this study is to describe the situation of COVID-19 in European countries and to identify important factors related to prevention and control. METHODS: We obtained data from World Health Statistics 2020 and the Institute for Health Metrics and Evaluation (IHME). We calcula...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yan, Yu, Qiuyan, Wen, Haoyu, Shi, Fang, Wang, Fang, Zhao, Yudi, Hong, Qiumian, Yu, Chuanhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743060/ https://www.ncbi.nlm.nih.gov/pubmed/35000583 http://dx.doi.org/10.1186/s13756-021-01039-x

Ejemplares similares

Non-pharmacological interventions of travel restrictions and cancelation of public events had a major reductive mortality affect during pre-vaccination coronavirus disease 2019 period
por: Wen, Haoyu, et al.
Publicado: (2022)

The comparison of epidemiological characteristics between confirmed and clinically diagnosed cases with COVID-19 during the early epidemic in Wuhan, China
por: Shi, Fang, et al.
Publicado: (2021)

Lung Cancer Death Attributable to Long-Term Ambient Particulate Matter (PM(2.5)) Exposure in East Asian Countries During 1990–2019
por: Liu, Xiaoxue, et al.
Publicado: (2021)

Commentary: Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe
por: Kuhbandner, Christof, et al.
Publicado: (2020)

The best pharmaceuticals for children—what can we do?
por: Li, Hao, et al.
Publicado: (2020)

Emergency Preparedness and Management of Mobile Cabin Hospitals in China During the COVID-19 Pandemic
por: Shi, Fang, et al.
Publicado: (2022)

Trends in Deaths Attributable to Smoking in China, Japan, United Kingdom, and United States From 1990 to 2019
por: Wen, Haoyu, et al.
Publicado: (2022)

A dataset of non-pharmaceutical interventions on SARS-CoV-2 in Europe
por: Altman, George, et al.
Publicado: (2022)

Association of Serum 25(OH)D, Cadmium, CRP With All-Cause, Cause-Specific Mortality: A Prospective Cohort Study
por: Liu, Yan, et al.
Publicado: (2022)

Comparison of trend in chronic kidney disease burden between China, Japan, the United Kingdom, and the United States
por: Wen, Haoyu, et al.
Publicado: (2022)

Trends in Disease Burden Attributable to Tobacco in China, 1990–2017: Findings From the Global Burden of Disease Study 2017
por: Wen, Haoyu, et al.
Publicado: (2020)

Impact of Particulate Matter on Hospitalizations for Respiratory Diseases and Related Economic Losses in Wuhan, China
por: Qin, Guiyu, et al.
Publicado: (2022)

The epidemiological characteristics of deaths with COVID-19 in the early stage of epidemic in Wuhan, China
por: Bai, Jianjun, et al.
Publicado: (2020)

Correction to: The epidemiological characteristics of deaths with COVID-19 in the early stage of epidemic in Wuhan, China
por: Bai, Jianjun, et al.
Publicado: (2020)

Making pharmaceutical companies report what matters about innovation
por: Cohen, Adam, et al.
Publicado: (2021)

Attributable Risk and Economic Cost of Cardiovascular Hospital Admissions Due to Ambient Particulate Matter in Wuhan, China
por: Wang, Xuyan, et al.
Publicado: (2020)

Pharmaceutical distribution remuneration in Europe
por: Vogler, Sabine, et al.
Publicado: (2015)

Secular Trend of Cancer Death and Incidence in 29 Cancer Groups in China, 1990–2017: A Joinpoint and Age–Period–Cohort Analysis
por: Liu, Xiaoxue, et al.
Publicado: (2020)

Epidemiological characteristics of patients with severe COVID-19 infection in Wuhan, China: evidence from a retrospective observational study
por: Wang, Fang, et al.
Publicado: (2020)

The Association of Hypertension With the Severity of and Mortality From the COVID-19 in the Early Stage of the Epidemic in Wuhan, China: A Multicenter Retrospective Cohort Study
por: Mubarik, Sumaira, et al.
Publicado: (2021)

Corrigendum to: Epidemiological characteristics of patients with severe COVID-19 infection in Wuhan, China: evidence from a retrospective, observational study
por: Wang, Fang, et al.
Publicado: (2021)

Global Epidemiological Patterns in the Burden of Main Non-Communicable Diseases, 1990–2019: Relationships With Socio-Demographic Index
por: Bai, Jianjun, et al.
Publicado: (2023)

Effect of non-pharmaceutical interventions to contain COVID-19 in China
por: Lai, Shengjie, et al.
Publicado: (2020)

Difference in Long-Term Trends in COPD Mortality between China and the U.S., 1992–2017: An Age–Period–Cohort Analysis
por: Wen, Haoyu, et al.
Publicado: (2019)

A Long-Term Trend Study of Tuberculosis Incidence in China, India and United States 1992–2017: A Joinpoint and Age–Period–Cohort Analysis
por: Cui, Yiran, et al.
Publicado: (2020)

Influenza pandemic intervention planning using InfluSim: pharmaceutical and non- pharmaceutical interventions
por: Duerr, Hans P, et al.
Publicado: (2007)

Impact of non-pharmaceutical interventions during COVID-19 pandemic on measles and mumps in Mainland China()()()()
por: Xu, Jie, et al.
Publicado: (2023)

Impact of non-pharmaceutical interventions against COVID-19 in Europe in 2020: a quasi-experimental non-equivalent group and time series design study
por: Hunter, Paul R, et al.
Publicado: (2021)

Optimal control of the coronavirus pandemic with both pharmaceutical and non-pharmaceutical interventions
por: Oke, Segun I., et al.
Publicado: (2023)

Effect of COVID-19 Non-Pharmaceutical Interventions and the Implications for Human Rights
por: Hong, Seung-Hun, et al.
Publicado: (2020)

Secular trends in chronic respiratory diseases mortality in Brazil, Russia, China, and South Africa: a comparative study across main BRICS countries from 1990 to 2019
por: Bai, Jianjun, et al.
Publicado: (2022)

Non Pharmaceutical Interventions for Optimal Control of COVID-19
por: Zamir, Muhmmad, et al.
Publicado: (2020)

Adoption and impact of non-pharmaceutical interventions for COVID-19
por: Imai, Natsuko, et al.
Publicado: (2020)

Effect of non-pharmaceutical interventions for containing the COVID-19 outbreak in China
por: Lai, Shengjie, et al.
Publicado: (2020)

Non-Pharmaceutical Interventions Implemented to Control the COVID-19 Were Associated With Reduction of Influenza Incidence
por: Huang, Qing-Mei, et al.
Publicado: (2022)

Non-pharmaceutical interventions and the emergence of pathogen variants
por: Ashby, Ben, et al.
Publicado: (2022)

Non-pharmaceutical interventions to optimize cancer immunotherapy
por: Boesch, Maximilian, et al.
Publicado: (2023)

Optimal Control of the COVID-19 Pandemic with Non-pharmaceutical Interventions
por: Perkins, T. Alex, et al.
Publicado: (2020)

Early adoption of non-pharmaceutical interventions and COVID-19 mortality
por: Amuedo-Dorantes, Catalina, et al.
Publicado: (2021)

Non-Pharmaceutical Interventions and COVID-19 Burden in the United States
por: Ahlers, Michael J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mb7v7gg48ad216g64nr5ase9mf